MAPK8 and cancer: Inaddition, research found that the DNA-targeted drugs XR5944[43], HSP90, and DDX39B inhibitor CCT018159[44], farnesyl transferase inhibitorFTI-277 [45], and the JNK inhibitor VIII[46] with potential cancer therapeuticeffects are related to the risk score of LUAD individuals.